Arkolith/Insider Trading/RLMD/Form 4

Traversa Sergio

Chief Executive Officer, DirectorRELMADA THERAPEUTICS, INC. (RLMD) · full profile →Form 4 · filed May 20, 2025
Net Buying
Open-Market Buys
$175K
Open-Market Sells
$0
Net Open-Market Flow
$175K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2025Buy(P)148K$0.56$83K734K
May 19, 2025Buy(P)30K$0.50$15K586K
May 16, 2025Buy(P)172K$0.45$78K556K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-046085) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML